BOS
GWPH

Bingham Osborn & Scarborough’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bingham Osborn & Scarborough’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,450
Closed -$1.02M – 171
2020
Q3 		$1.02M Buy
+10,450
New +$1.2M 0.08% 63

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bingham Osborn & Scarborough's GWPH Position: Q4 2020 in Review

Bingham Osborn & Scarborough sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 10,450 shares — an estimated $1.02M sold.

Bingham Osborn & Scarborough first reported a position in GWPH in Q3 2020 and held it in 1 quarter. The position peaked at $1.02M in Q3 2020. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

  • Bingham Osborn & Scarborough reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
  • Bingham Osborn & Scarborough sold 10,450 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $1.02M.
  • Bingham Osborn & Scarborough first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2020 and held it in 1 quarter.
  • Bingham Osborn & Scarborough's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.02M in Q3 2020.
  • 279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Bingham Osborn & Scarborough's 13F filing for Q4 2020, filed 11 Feb 2021.